Search results
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 2 months agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Merck scraps third prostate cancer study as Keytruda therapy disappoints
Reuters via Yahoo News· 1 year agoMerck & Co on Tuesday scrapped a late-stage trial of a combination therapy with its cancer drug...
Merck could keep its patent edge by shifting Keytruda cancer drug to a simple shot
Reuters via Yahoo News· 2 years agoU.S. drugmaker Merck & Co hopes to patent a new formulation of its $20 billion cancer immunotherapy...
15 Best Hospitals for Cancer Treatment in the US
Insider Monkey via Yahoo Finance· 4 months agoIn this article, we will be taking a look at the 15 best hospitals for cancer treatment in the US. If you are not interested in reading about the global...
Merck Stock Has Been A Laggard For Seven Months. Is It Staging A Comeback?
Investor's Business Daily· 5 months agoMerck stock is shrugging off seven months of underperformance, shooting more than 7% higher in the...
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 3 weeks agoWatching his brother slowly die was enough to convince Filko Prugo he didn't want to go the same...
Cancer vaccines are already a reality—but your doctor might not tell you about them unless you ask
Fortune via Yahoo Finance· 1 year agoCancer vaccines—it’s a concept seemingly torn from the plot of a futuristic sci-fi movie, or from...
Patients with incurable cervical cancer to be offered new drug
Press Association News via AOL· 1 year agoPatients with incurable cervical cancer are to be offered a new treatment which could give them more...
Why Amgen's Cancer Drug Results Gave This Small Cap A Big Boost
Investor's Business Daily· 2 years agoAmgen stock jumped Wednesday after outperforming expectations in a lung-cancer study. It brought...
Moderna (MRNA), Merck's Cancer Jab Delays Melanoma Recurrence
Zacks via Yahoo Finance· 1 year agoModerna MRNA and partner Merck MRK announced detailed results from the phase IIb KEYNOTE-942 study,...